// App-Quantinova.ai

3638 : Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial

Researchers

Presenter

  • Xianchen Liu

Principal Investigators

  • John Thompson

  • Hemant Phatak

  • Jack Mardekian

  • Anthony R. Porcari

  • Margot R. Johnson

Medical Centers

  • College of Pharmacy, University of Tennessee, Memphis, TN

Locations

  • United States

Companies

  • Pfizer Inc.

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim